FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/05/2022
Back to search
Official data from USPTO
KD-PÜR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
KD-PÜR
ST13
US500000079294557Class
5, 40, 42
Filing
79294557
Registration
6674408
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
09/05/2022
Trademark type
Word
Nice classes
5, 40, 42
Filing date
07/22/2020
Registration date
03/22/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/22/2022
Last transaction
03/22/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
27
Owner location
DE
Examiner
CLARKE, NANCY
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
K.D. Pharma Bexbach GmbH
Representatives
Christian Wolff Schock Rechtsanwaelte GbR
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary productspharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorderspharmaceutical products for the prevention and treatment of cancerpharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorderspharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti - infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccineschemical reagents for medical or veterinary purposes; sanitary preparations for medical use; dietetic foodstuffs and preparations for medical or veterinary purposesdietetic foods and beverages adapted for medical usedietetic foods adapted for veterinary usedietetic beverages adapted for veterinary usedietetic preparations adapted for medical purposes; dietary supplements for humans and animals; pharmaceutical products in the nature of oilspowders and capsules containing omega-3-extracts for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; nutritional supplements; dietetic preparations adapted for medical purposes containing omega-3-extracts and in the form of oilspowders and capsules containing omega-3-extracts
Class 40
Contract manufacturing for others of pharmaceutical productsdietary supplements and dietetic products for medical purposes containing omega-3-extracts in the form of oilspowders and capsules
Class 42
Scientific and technological servicespharmaceutical research and developmentpharmaceutical products developmenttesting of pharmaceuticalsdevelopment of pharmaceutical preparations and medicinesscientific research in the field of pharmaceuticalspharmaceutical research serviceslaboratory research services relating to pharmaceuticalsscientific analysis in the field of nutritional supplements; scientific research and development in the field of lipid extraction from natural resources; scientific laboratory services; chemical laboratories; scientific and industrial research for others relating to the manufacture of pharmaceutical productsdietary supplements and dietetic products for medical purposes containing omega-3-extracts in the form of oilspowders and capsules
Publications
History of USPTO decisions and trademark events.
35 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/16/2022
FIMP
FINAL DISPOSITION PROCESSED
08/16/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/22/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
03/22/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/21/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/02/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/02/2022
GPNX
NOTIFICATION PROCESSED BY IB
01/22/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/04/2022
PUBO
PUBLISHED FOR OPPOSITION
01/04/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/15/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/15/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/15/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/27/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/25/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/25/2021
DMCC
DATA MODIFICATION COMPLETED
06/01/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/01/2021
GNFR
FINAL REFUSAL E-MAILED
06/01/2021
CNFR
FINAL REFUSAL WRITTEN
06/01/2021
ALIE
ASSIGNED TO LIE
06/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/06/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/06/2021
RFNT
REFUSAL PROCESSED BY IB
12/13/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/25/2020
RFRR
REFUSAL PROCESSED BY MPU
11/24/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/08/2020
CNRT
NON-FINAL ACTION WRITTEN
11/07/2020
DOCK
ASSIGNED TO EXAMINER
11/06/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/29/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/24/2020
Continuous trademark protection
Get notified about every new filing that threatens KD-PÜR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.